LDS/Medical Tests/Interferon-γ Receptor (IFNGR1) Deficiency

Interferon-γ Receptor (IFNGR1) Deficiency

Interferon gamma receptor 1 (IFNGR1) gene encodes the ligand-binding chain of the gamma interferon receptor, which is found on macrophages. IFNGR1, in conjunction with IFNGR2, activates the cellular response of interferon gamma, which is a cytokine that is necessary for innate immunity to certain viruses and bacteria.  Mutations in four genes, IFNGR1, IFNGR2, IL12B and IL12RB1, are a rare cause of Mendelian susceptibility to mycobacterial disease (MSMD). MSMD is an autosomal recessive genetic immunity disease that causes the inability to clear a mycobacterial infection and creates a predisposition to this illness. Severity of the disease is dependent on the exact mutation(s) and whether a homozygous or heterozygous mutation is present.  There are both allelic and non-allelic mutations resulting in eight types of disease.  The common defect in all eight is impaired interferon-gamma mediated immunity.  

The severity of the phenotypic illness depends upon the mutation(s) present.  Those who are homozygous for the mutation are completely deficient in INFGR1 and symptoms are severe and often fatal. Some patients will develop lesions in their lungs and die of mycobacterial disease and others will have infections that are treatable with antibiotics and interferon-gamma therapy. Severe disease is only curable by stem cell transplant. The infections can occur at any time in life and can persist for months to years at a time. Disease can be caused by the vaccination to tuberculosis, Bacillus calmette-Guerin (BCG) vaccine, non-tuberculosis Mycobacteria, or Mycobacteria tuberculosis itself. Genetic testing can confirm a clinical diagnosis of IFNGR1 deficiency, determine how the disease was inherited, and find the mutations that are present within the affected families.

  • Confirm a clinical diagnosis of IFNGR1 deficiency
  • Explain recurrent mycobacterial infections with unknown origin
  • Determining mutations present within families
  • Aid in determining which treatment is needed for illness
  • Exclusion of other causes of immunodeficiency
A mutation present in the INFGR1 gene is indicative of complete or partial deficiency of INFGR1 and is supportive of a diagnosis of MSMD.

Negative for mutations analyzed
 

 

 

Amplification by polymerase chain reaction (PCR); sequencing of entire protein-coding region.

Whole blood (EDTA), buccal swab.

Stability

  • Ambient: 1-3 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Interferon gamma receptor 2, Flow cytometry panel, mycobacterial culture, mycobacterium by PCR, Immunoglobulin Profile, HIV.
14-21 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Lancet. 2004; 364(9451):2113-21. [PMID: 15589309]
  • J Soc Biol. 2000;194(1):25-8. [PMID: 11107546]
  • Pediatr Res. 2001; 50(1):8-13. [PMID: 11420412]
  • Immunol Rev. 2005; 203:38-47. [PMID: 15661020]
  • IFNGR1. (2011, May 22). Retrieved May 31, 2011, from Genetics Home Reference: http://ghr.nlm.nih.gov/gene/IFNGR1
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login